Tursi A - Search Results

1

Pembrolizumab-induced acute diverticulitis.

Tursi A. Tursi A. Minerva Gastroenterol (Torino). 2023 Jun;69(2):317-318. doi: 10.23736/S2724-5985.21.02894-1. Epub 2021 May 12. Minerva Gastroenterol (Torino). 2023. PMID: 33978389 No abstract available.

2

Predictive value of serologic markers of degree of histologic damage in acute uncomplicated colonic diverticulitis.

Tursi A, Elisei W, Brandimarte G, Giorgetti GM, Aiello F. Tursi A, et al. J Clin Gastroenterol. 2010 Nov-Dec;44(10):702-6. doi: 10.1097/MCG.0b013e3181dad979. J Clin Gastroenterol. 2010. PMID: 20485187

3

Preventing diverticulitis recurrence by selecting the right therapy for a complex disease.

Tursi A, Danese S. Tursi A, et al. Gastroenterology. 2014 Oct;147(4):733-6. doi: 10.1053/j.gastro.2014.08.022. Epub 2014 Sep 11. Gastroenterology. 2014. PMID: 25167986 No abstract available.

4

New medical strategies for the management of acute diverticulitis.

Tursi A. Tursi A. Expert Rev Gastroenterol Hepatol. 2015;9(10):1293-304. doi: 10.1586/17474124.2015.1075881. Epub 2015 Aug 6. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26289102 Review.

5

Recent advances in the treatment of colonic diverticular disease and prevention of acute diverticulitis.

Elisei W, Tursi A. Elisei W, et al. Among authors: tursi a. Ann Gastroenterol. 2016 Jan-Mar;29(1):24-32. Ann Gastroenterol. 2016. PMID: 26752946 Free PMC article. Review.

6

Immune checkpoint inhibitors-induced acute diverticulitis.

Tursi A. Tursi A. Eur J Gastroenterol Hepatol. 2020 Jul;32(7):893-895. doi: 10.1097/MEG.0000000000001713. Eur J Gastroenterol Hepatol. 2020. PMID: 32472816 No abstract available.

7

Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease.

Brandimarte G, Frajese GV, Bargiggia S, Castellani D, Cocco A, Colucci R, Evangelista E, Gravina AG, Napoletano D, Nardi E, Maisto T, Morabito A, Pianese G, Romano A, Sacco R, Sediari L, Sinnona N, Tifi L, D'Avino A, Elisei W, Tursi A. Brandimarte G, et al. Among authors: tursi a. Minerva Gastroenterol (Torino). 2022 Jun;68(2):216-222. doi: 10.23736/S2724-5985.22.03132-1. Epub 2022 Mar 8. Minerva Gastroenterol (Torino). 2022. PMID: 35262307

8

Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.

Tursi A, Brandimarte G, Daffinà R. Tursi A, et al. Dig Liver Dis. 2002 Jul;34(7):510-5. doi: 10.1016/s1590-8658(02)80110-4. Dig Liver Dis. 2002. PMID: 12236485

9

Assessment of small intestinal bacterial overgrowth in uncomplicated acute diverticulitis of the colon.

Tursi A, Brandimarte G, Giorgetti GM, Elisei W. Tursi A, et al. World J Gastroenterol. 2005 May 14;11(18):2773-6. doi: 10.3748/wjg.v11.i18.2773. World J Gastroenterol. 2005. PMID: 15884120 Free PMC article.

10

Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon.

Tursi A. Tursi A. J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 1:S119-22. doi: 10.1097/MCG.0b013e31815f5ac7. J Clin Gastroenterol. 2008. PMID: 18806701 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

531 results

Search Page